Heron Therapeutics Inc (NASDAQ: HRTX) on Friday, soared 3.93% from the previous trading day, before settling in for the closing price of $1.78. Within the past 52 weeks, HRTX’s price has moved between $0.50 and $3.93.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 17.85% annually for the last half of the decade. The company achieved an average annual earnings per share of 84.19%. With a float of $144.07 million, this company’s outstanding shares have now reached $150.29 million.
In an organization with 126 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 65.49%, operating margin of -34.02%, and the pretax margin is -35.29%.
Heron Therapeutics Inc (HRTX) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Heron Therapeutics Inc is 5.01%, while institutional ownership is 81.09%. The most recent insider transaction that took place on Nov 17 ’23, was worth 27,250. In this transaction EVP, Chief Development Officer of this company bought 25,000 shares at a rate of $1.09, taking the stock ownership to the 79,000 shares. Before that another transaction happened on Nov 16 ’23, when Company’s EVP, Chief Development Officer bought 50,000 for $0.94, making the entire transaction worth $46,995. This insider now owns 54,000 shares in total.
Heron Therapeutics Inc (HRTX) Latest Financial update
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.17 earnings per share (EPS) for the period topping the consensus outlook (set at -0.29) by 0.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 84.19% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 47.50% during the next five years compared to 20.01% growth over the previous five years of trading.
Heron Therapeutics Inc (NASDAQ: HRTX) Trading Performance Indicators
Heron Therapeutics Inc (HRTX) is currently performing well based on its current performance indicators. A quick ratio of 1.85 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.33, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach -0.02 in one year’s time.
Technical Analysis of Heron Therapeutics Inc (HRTX)
Let’s dig in a bit further. During the last 5-days, its volume was 1.53 million. That was inferior than the volume of 2.43 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 58.00%. Additionally, its Average True Range was 0.12.
During the past 100 days, Heron Therapeutics Inc’s (HRTX) raw stochastic average was set at 16.80%, which indicates a significant decrease from 75.68% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.47% in the past 14 days, which was lower than the 85.47% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.8982, while its 200-day Moving Average is $2.6085. However, in the short run, Heron Therapeutics Inc’s stock first resistance to watch stands at $1.9000. Second resistance stands at $1.9500. The third major resistance level sits at $2.0150. If the price goes on to break the first support level at $1.7850, it is likely to go to the next support level at $1.7200. The third support level lies at $1.6700 if the price breaches the second support level.
Heron Therapeutics Inc (NASDAQ: HRTX) Key Stats
Market capitalization of the company is 280.59 million based on 150,653K outstanding shares. Right now, sales total 127,040 K and income totals -110,560 K. The company made 36,020 K in profit during its latest quarter, and -9,240 K in sales during its previous quarter.
